Yield10 Bioscience to Host Webcast of its Third Quarter 2017 Conference Call
06 nov. 2017 08h30 HE
|
Yield10 Bioscience, Inc.
WOBURN,Mass., Nov. 06, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced today that the Company plans to release its third quarter 2017 financial results and host a...
Yield10 Bioscience to Participate in U.S. Department of Energy Grant for Boosting Oilseed Yield in Camelina
15 sept. 2017 08h30 HE
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Sept. 15, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced today that it will be a subawardee on a new U.S. Department of Energy (DOE) Grant to conduct...
Yield10 Bioscience Obtains Confirmation of Nonregulated Status from USDA-APHIS for its Genome-edited Camelina Line
05 sept. 2017 08h35 HE
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced today that it has received a positive response from USDA-APHIS’s Biotechnology Regulatory Services...
Yield10 Bioscience to Present at the 19th Annual Rodman & Renshaw Global Investment Conference
05 sept. 2017 08h30 HE
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN), a Company focused on developing new technologies to achieve step-change improvements in crop yield to...
Yield10 Bioscience Announces Second Quarter 2017 Financial Results
10 août 2017 16h05 HE
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Aug. 10, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) today reported financial results for the three months ended June 30, 2017. “We made solid progress in the...
Yield10 Bioscience Announces Collaboration with National Research Council of Canada to Improve Yield and Drought Tolerance in Wheat
08 août 2017 09h00 HE
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Aug. 08, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced today that its wholly owned Canadian subsidiary, Metabolix Oilseeds, Inc., has signed a...
Yield10 Bioscience to Host Webcast of its Second Quarter 2017 Conference Call
27 juil. 2017 09h00 HE
|
Yield10 Bioscience, Inc.
WOBURN, Mass., July 27, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced today that the Company plans to release its second quarter 2017 financial results and host a...
Yield10 Bioscience Announces Pricing of $2.3 Million Registered Direct Offering
03 juil. 2017 08h30 HE
|
Yield10 Bioscience, Inc.
WOBURN, Mass., July 03, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) today announced that it has entered into a securities purchase agreement with certain new institutional...
Yield10 Bioscience to Report Results Showing that Trait C4001 Produces Significant Increases in Plant Yield
27 juin 2017 08h30 HE
|
Yield10 Bioscience, Inc.
WOBURN, Mass., June 27, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced that the Company’s novel C4001 trait, a global regulatory gene or transcription factor, has been...
Yield10 Bioscience CEO Dr. Oliver Peoples to Present at BIO 2017
20 juin 2017 09h00 HE
|
Yield10 Bioscience, Inc.
WOBURN, Mass., June 20, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced that CEO Oliver Peoples, Ph.D., will be presenting today at BIO 2017 on a panel entitled:...